ScreenCell® enables rapid, reliable, and cost-effective isolation of circulating tumor cells (CTCs) from a simple blood sample.
We are transforming circulating tumor cell research into concrete solutions to improve cancer patient care.
+90%
circulating tumor cells recovery rate.
Explore the full range of ScreenCell® kits, each specifically designed to meet the diverse needs of liquid biopsy applications.
Blood sample
< 3 days
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Blood sample
< 4 hours
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Explore over 70 scientific articles authored by our customers and partners.
